Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
CH0038389992
Mon, 20.05.2024
Edison Investment Research Limited
London, UK, 20 May 2024
Edison issues review on BB Biotech (BION): A recovering sector with a healthy prognosis
BB Biotech (BION) offers investors exposure to the innovative, rapidly expanding biotech sector. It is the largest biotech investor among its investment company peers, focused on high-quality biotech assets that target substantial [ … ]
Thu, 21.03.2024
BB BIOTECH AG
Media release of March 21, 2024
Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.00 per share
All proposals of BB Biotech AG's Board of Directors were approved by BB Biotech AG's shareholders at its Annual General Meeting held today.
Shareholders voted in favor of the proposal to pay out a divi [ … ]
Wed, 14.02.2024
BB BIOTECH AG
Release as at February 14, 2024Investor interest returns – dividend yield remains high for 2024
After a difficult 2023 stock market year, above all due to higher interest rates, the capital markets are now once again looking at biotech companies with interest. The prospect of falling interest rates has led to a rethink. While the majority of inves [ … ]
Fri, 19.01.2024
BB BIOTECH AG
Media release as at January 19, 2024
Portfolio of BB Biotech AG as at December 31, 2023
End of year biotech equity market rally – M&A and end of rate hike cycle
In 2023, global equity performed better than anticipated by many. The US central bank moderated and then paused interest rate hikes. These developments resulted in a year-end bond ma [ … ]
Fri, 20.10.2023
BB BIOTECH AG
Media release as at October 20, 2023
Interim report of BB Biotech AG as at September 30, 2023
Biotech equity markets in flux: the impact of rising bond yields and shifting healthcare policies
Expectations that the US central bank would soon reverse its monetary policy stance proved to be premature. The rise in bond yields weighed heavily on biot [ … ]
Fri, 21.07.2023
BB BIOTECH AG
Media release as at July 21, 2023
Interim report of BB Biotech AG as at June 30, 2023
Sector rotation and fund outflows weigh on biotech stocks, but positive developments allow fund raising to strengthen industry
The first half of 2023 has been disappointing for biotech investors. A massive rotation has put biotech stocks under pressure. Whereas [ … ]
Fri, 21.07.2023
BB BIOTECH AG
Media release as at July 21, 2023
Interim report of BB Biotech AG as at June 30, 2023
Sector rotation and fund outflows weigh on biotech stocks, but positive developments allow fund raising to strengthen industry
The first half of 2023 has been disappointing for biotech investors. A massive rotation has put biotech stocks under pressure. Whereas [ … ]
Wed, 03.05.2023
BB BIOTECH AG
Expert commentary
Creating blockbuster drugs using algorithms
Artificial intelligence is becoming an increasingly important tool in the drug discovery and development process. Biotech investors benefit from this technology too.
Dr. Samuel Croset, Data Scientist BB Biotech at Bellevue Asset Management
Artificial intelligence and machine-learning [ … ]
Wed, 03.05.2023
BB BIOTECH AG
Expert commentary
Creating blockbuster drugs using algorithms
Artificial intelligence is becoming an increasingly important tool in the drug discovery and development process. Biotech investors benefit from this technology too.
Dr. Samuel Croset, Data Scientist BB Biotech at Bellevue Asset Management
Artificial intelligence and machine-learning [ … ]
Fri, 21.04.2023
BB BIOTECH AG
Media release as at April 21, 2023
Interim report of BB Biotech AG as at March 31, 2023
Lackluster first quarter for biotech stocks
Concerns about capital market resilience clearly had an impact on investor preferences during the first quarter. After a strong start to the year, market sentiment switched to risk-off and this triggered heavy sellin [ … ]